The Case for and Against Puma Biotechnology, Inc. (PBYI) – StockNewsJournal

Posted: June 7, 2017 at 6:48 am


Analyst Ratings
The Case for and Against Puma Biotechnology, Inc. (PBYI)
StockNewsJournal
Puma Biotechnology, Inc. (PBYI) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $83.65, up from yesterday's close by 2.07%. Given the stock's recent action, it ...
What Should Investors Make Of The Trading Chart Of Puma Biotechnology, Inc. (PBYI)?NY Stock News
Puma Biotechnology Gets a Buy Rating from Cowen & Co.Analyst Ratings
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at Stifel NicolausSports Perspectives
The Cerbat Gem -StockNewsMagazine -Free Observer -Zacks
all 31 news articles »

Continue reading here:
The Case for and Against Puma Biotechnology, Inc. (PBYI) - StockNewsJournal

Related Posts